At its March meeting, the PBAC has recommended the removal of age restrictions from all PBS listings of hepatitis C DAA regimens.
If you have ever been infected by hepatitis B, cancer treatment which suppresses your immune system can allow the virus to reactivate – even if your body had dealt with it successfully before.
Reactivation can lead to liver failure, death or sub-optimal cancer treatment.
Migration & Hep B | Hep C Elimination | Shuping Wang | Elimination Conference Highlights | Treatment Priorities | Treatment & Homelessness | What's On? | In Our Library
Australians from all walks of life can have hepatitis B or C, but a third of a million aren’t coming forward for vital treatment that can save their lives.
LiveR Life | Immunosuppression | Resources | Liver Health Days | Viral Hepatitis Nurses | The Latest Data | What's On? | In Our Library
Hepatitis Australia has called on the Australian Government to provide adequate funding to tackle the problems of hepatitis B and hepatitis C, so as to reduce liver cancers and avoidable deaths.
Our TEST CURE LIVE quiz draw winners are Ms Sandra Jennings and Barbara Nowak.
Try a little kindness |CNP peers spread treatment news |Back on Track |Missing thousands |Where are we with Hep B? |Malaysia takes on hep C & big pharma |Patient centred information videos & more...
Fatty Liver Disease | Natural HCV Immunity | Considering Treatment? | Detox or Not? | Ilbijerri Theatre | SA Health Awards | Research Update | Healthcare Workers & BBVs New Guidelines and more...
Australian researchers have found a way to predict the risk of liver cancer in people with chronic hepatitis B, promising earlier diagnosis, better management and potentially better prevention of hepatitis B- related liver cancer.
Hepatitis Australia has welcomed the support for an immediate increase in funding to help achieve the National Strategy targets.
National Blood Borne Viruses (BBV) and Sexually Transmissible Infections (STI) Strategies for 2018-22 have been released by the Department of Health.
